Our new hospital will house the state-of-the-art CCRI (Cambridge Children's Research Institute), solely dedicated to improving the health of children and young people.
Shifting the dial from reactive to preventative care.
The innovative and creative thinking that has led to 107 Nobel Prizes - 37 of which have been awarded in Medicine and Chemistry - is the engine powering the Cambridge Children’s Research Institute.
At Cambridge, innovation is in our DNA.
It was here that Watson, Crick, and Franklin revealed the structure of DNA. Where Frederick Sanger sequenced the human genome. And where Cambridge chemists made sequencing fast and affordable enough to be used in the clinic.
These are the foundations we’re built on. From the foundations, we will use genomic medicine to radically transform children’s healthcare.
Cambridge Children’s will sit at the heart of the Cambridge Biomedical Campus – Europe’s leading life science hub.
Combining world-class biomedical research, outstanding patient care, and clinical education, the Campus provides an exceptional environment that can revolutionise our approach to children’s health.
We’ll also will work alongside local partners from associated institutions such as the MRC Laboratory of Molecular Biology, and one of the world’s premier centres of genomic discovery, the Wellcome Sanger Institute.
By helping us improve how we treat those young people unfortunate enough to be affected by serious childhood diseases, the new hospital has the potential to transform provision of healthcare for families in the East of England.
Prof Stephen Toope, Vice-Chancellor, University of Cambridge
The 5000m2 Research Institute will house six collaborative research centres to radically transform the prevention, diagnosis and treatment of children’s illness.
It will concentrate wide-ranging research efforts across children’s health in one state-of-the-art facility, building on Cambridge University’s tradition of life-changing biomedical discovery and scientific innovation.
New cutting-edge technology will help us target the drivers of disease and deliver gene and cell therapies for even the rarest conditions.
It will deepen our understanding and stretch our thinking, generating data at a large scale that we can use to predict, prevent, and pave the way so that fewer children get ill and those who do recover sooner.